Boehringer Ingelheim Pharmaceuticals Inc is a clinical research site located in Ridgefield, Connecticut, United States 06879.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Boehringer Ingelheim Pharmaceuticals Inc has participated in 2 clinical trials.
Therapeutic areas: Diabetes Mellitus, Type 2, Cardiovascular Diseases, HIV Infections.
Sponsors: Boehringer Ingelheim.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boehringer Ingelheim Pharmaceuticals Inc has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boehringer Ingelheim Pharmaceuticals Inc has 2 clinical trials on record. Their work covers Diabetes Mellitus, Type 2, Cardiovascular Diseases, HIV Infections.
Boehringer Ingelheim Pharmaceuticals Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.